Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep 7;2011(9):CD000064.
doi: 10.1002/14651858.CD000064.pub2.

Corticosteroids for acute ischaemic stroke

Peter Ag Sandercock  1 , Tim Soane
Affiliations

Corticosteroids for acute ischaemic stroke

Peter Ag Sandercock et al. Cochrane Database Syst Rev. .

Abstract

Background: The majority of strokes are due to cerebral infarction. Ischaemic cerebral tissue tends to develop cytotoxic oedema which, if the blood-brain barrier is disrupted, may be followed by vasogenic oedema. Large infarcts can develop life-threatening massive oedema. Early treatment with corticosteroids could theoretically help reduce both cytotoxic and vasogenic oedema and so improve the clinical outcome after a stroke.

Objectives: To assess the effect of corticosteroids in acute presumed ischaemic stroke.

Search strategy: We searched the Cochrane Stroke Group Trials Register (last searched: 17 February 2011).

Selection criteria: Published randomised trials comparing corticosteroids with placebo or a control group in people with acute (presumed or definite) ischaemic stroke. Trials were included if treatment began within 48 hours of stroke onset and if clinical outcomes were assessed.

Data collection and analysis: Two review authors independently applied the inclusion criteria, assessed trial quality and extracted the data.

Main results: Eight trials involving 466 people were included. Details of trial quality that may relate to bias were not available for most trials. No difference was shown in the odds of death within one year (odds ratio (OR) 0.87, 95% confidence interval (CI) 0.57 to 1.34). Treatment did not appear to improve functional outcome in survivors. Seven trials reported neurological impairment but pooling the data was impossible because no common scale or time interval was used. The results were inconsistent between individual trials. The only adverse effects reported were small numbers of gastrointestinal bleeds, infections and deterioration of hyperglycaemia across both groups. The results are unchanged since the previous update.

Authors' conclusions: There is not enough evidence to evaluate corticosteroid treatment for people with acute presumed ischaemic stroke. The conclusions are unchanged since the previous update.

PubMed Disclaimer

Conflict of interest statement

None known

Figures

1.1
1.1. Analysis
Comparison 1 Corticosteroids versus placebo, Outcome 1 All deaths.
1.2
1.2. Analysis
Comparison 1 Corticosteroids versus placebo, Outcome 2 Deaths within one month.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Bauer 1973 {published data only}
    1. Bauer RB, Tellez H. Dexamethasone as treatment in cerebrovascular disease. 2. A controlled study in acute cerebral infarction. Stroke 1973;4:547‐55. - PubMed
Gupta 1978 {published data only}
    1. Gupta RC, Bhatnagar HN, Gambhir MS, Shah DR. Betamethasone therapy in acute cerebrovascular accidents. Journal of the Association of Physicians of India 1978;26:589‐94. - PubMed
McQueen 1978 {published and unpublished data}
    1. McQueen EG. Betamethasone in stroke. New Zealand Medical Journal 1978;87:103‐4. - PubMed
Mulley 1978 {published and unpublished data}
    1. Mulley G, Wilcox RG, Mitchell JR. Dexamethasone in acute stroke. BMJ 1978;2:994‐6. - PMC - PubMed
Norris 1976 {published and unpublished data}
    1. Norris JW. Steroid therapy in acute cerebral infarction. Archives of Neurology 1976;33:69‐71. - PubMed
Norris 1986 {published and unpublished data}
    1. Norris JW, Hachinski VC. High dose steroid treatment in cerebral infarction. BMJ 1986;292:21‐3. - PMC - PubMed
Ogun 2001 {published data only}
    1. Ogun SA, Odusote KA. Effectiveness of high dose dexamethasone in the treatment of acute stroke. West African Journal of Medicine 2001;20(1):1‐6. - PubMed
Patten 1972 {published and unpublished data}
    1. Patten BM, Mendell J, Bruun B, Curtin W, Carter S. Double‐blind study of the effects of dexamethasone on acute stroke. Neurology 1972;22:377‐83. - PubMed

References to studies excluded from this review

Albizzati 1979 {published data only}
    1. Albizzati MG, Candelise L, Capitani E, Colombo A, Spinnler H. Association of stroke to dexamethasone in treatment of stroke patients. Acta Neurologica Scandinavica 1979;60:77‐84. - PubMed
Barolin 1976 {published data only}
    1. Barolin GS, Scholz H, Widhalm K, Hemmer W. Cortisone in non‐haemorrhagic stroke. An anterospective comparative study. Münchener Medizinische Wochenschrift 1976;118(36):1117‐20. - PubMed
Dyken 1956 {published data only}
    1. Dyken M, White PT. Evaluation of cortisone in the treatment of cerebral infarction. JAMA 1956;162:1531‐5. - PubMed
Freeman 1978 {published data only}
    1. Freeman J, Tappin J, Karat AB, Meecham J. Dexamethasone in acute stroke. BMJ 1978;2:1500. - PMC - PubMed
Gahlot 1982 {published data only}
    1. Gahlot SR, Goyal RK, Swaroop AK Mathur RN. Intravenous glycerol versus dexamethasone therapy in the management of acute cerebral oedema in patients with acute cerebral infarction. Journal of the Association of Physicians of India 1982;30:575‐8. - PubMed
Gilsanz 1975 {published data only}
    1. Gilsanz V, Rebollar JL, Buencuerpo J, Chantres MT. Controlled trial of glycerol versus dexamethazone in the treatment of cerebral oedema in acute cerebral infarction. Lancet 1975;1:1049‐51. - PubMed
Hasan 1989 {published data only}
    1. Hasan D, Lindsay KW, Wijdicks EFM, Murray GD, Brouwers PJAM, Bakker WH, et al. Effect of fludrocortisone acetate in patients with subarachnoid haemorrhage. Stroke 1989;20:1156‐61. - PubMed
Hetzel 1957 {published data only}
    1. Hetzel BS, Lander H, Robson HN. Immediate treatment of apoplexy. BMJ 1957;1:1122.
Kaste 1976 {published and unpublished data}
    1. Kaste M, Fogelholm R, Waltimo O. Combined dexamethasone and low‐molecular‐weight dextran in acute brain infarction: double‐blind study. BMJ 1976;2:1409‐10. - PMC - PubMed
Kumar 1989 {published data only}
    1. Kumar N, Jain S, Maheshwari MC. Role of dexamethasone in the outcome from acute stroke. Journal of the Association of Physicians of India 1989;3:315‐7. - PubMed
Paal 1981 {published data only}
    1. Paal G, Grossman W, Leshem D, Coelho‐Velho‐Groneburg P. Dexamethasone and stroke: The results of a clinical, EEG and CT‐study. 12th World Congress of Neurology: Kyoto. 1981.
Poungvarin 1987 {published and unpublished data}
    1. Poungvarin N, Bhoopat W, Viriyavejakul A, Rodprasert P, Buranasari P, Sukondhabhant S, et al. Effects of dexamethasone in primary supratentorial intracerebral haemorrhage. New England Journal of Medicine 1987;316:1229‐33. - PubMed
Rompel 1980 {published data only}
    1. Rompel C, Kramer W, Umlauf B, Ulm K, Hellhake T. Effect of dexamethasone phosphate in cerebral infarction compared with current standard therapy. Controlled double‐blind method. Die Medizinische Welt 1980;31:1370‐2. - PubMed
Rubinstein 1965 {published data only}
    1. Rubinstein MK. The influence of adrenocortical steroids on severe cerebrovascular accidents. Journal of Nervous and Mental disease 1965;141:291‐9. - PubMed
Russek 1955 {published data only}
    1. Russek HI, Russek AS, Zohman BL. Cortisone in immediate therapy of apoplectic stroke. JAMA 1955;2:102‐5. - PubMed
Santambrogio 1978 {published data only}
    1. Santambrogio S, Martinotti R, Sardello F, Porro F, Randazzo A. Is there a real treatment for stroke? Clinical and statistical comparison of different treatments in 300 patients. Stroke 1978;9:130‐2. - PubMed
Tellez 1973 {published data only}
    1. Tellez H, Rauer B. Dexamethasone as treatment in cerebrovascular disease.1. A controlled study in intracerebral haemorrhage. Stroke 1973;4:541‐54. - PubMed
Wright 1974 {published data only}
    1. Wright WB. High‐dosage dexamethasone in treatment of strokes in the elderly. Gerontologia Clinica 1974;16:88‐91. - PubMed

Additional references

Battistini 1981
    1. Battistini N. Oedema in ischemic cerebral lesions, pathophysiology and treatment. In: Loeb C editor(s). Studies in Cerebrovascular Disease. Milano: Mason Italia Editori, 1981:181‐94.
Chen 1997
    1. Chen ZM, Sandercock P, Xie JX, Peto R, Collins R, Liu LS. Hospital management of acute ischaemic stroke in China. Journal of Stroke and Cerebrovascular Diseases 1997;6:361‐7. - PubMed
CRASH 2005
    1. CRASH Trial Collaborators. Final results of MRC CRASH, a randomised placebo‐controlled trial of intravenous corticosteroids in adults with head injury ‐ outcomes at 6 months. Lancet 2004;365:1957‐9. - PubMed
Faulkes 1988
    1. Faulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank: design, methods and baseline characteristics. Stroke 1988;19:547‐54. - PubMed
Gomes 2005
    1. Gomes JA, Stevens RD, Lewin JJ 3rd, Mirski MA, Bhardwaj A. Glucocorticoid therapy in neurologic critical care. Critical Care Medicine 2005;33(6):1214‐24. - PubMed
Schulz 1995
    1. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Failure to conceal treatment allocation schedules in controlled trials influences estimates of treatment effects: an analysis of 250 trials in 33 meta‐analyses. Atlanta: Center for Disease control and prevention. JAMA 1995;273:408‐12. - PubMed
Shapiro 1975
    1. Shapiro HM. Intracranial hypertension: therapeutic and anaesthetic considerations. Anaesthesia 1975;43:445‐71. - PubMed
Staykov 2011
    1. Staykov D, Gupta R. Hemicraniectomy in malignant middle cerebral artery infarction. Stroke 2011;42:513‐6. - PubMed

References to other published versions of this review

Qizilbash 2002
    1. Qizilbash N, Lewington S, López‐Arrieta J. Corticosteroids for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD000064] - DOI - PubMed

Publication types